Oct. 03, 2024

JCR Affirmed AA-/Stable and J-1+ on Takeda Pharmaceutical

Jul. 09, 2024

JCR Assigned A Rating to Subordinated Loan of Takeda Pharmaceutical

Jun. 07, 2024

JCR Assigned A Rating to Subordinated Bonds of Takeda Pharmaceutical

Apr. 15, 2024

JCR Assigned Preliminary A Rating to Subordinated Bonds of Takeda Pharmaceutical

Sep. 08, 2023

JCR Assigned Preliminary AA- Rating to Shelf Registration of Takeda Pharmaceutical

Jul. 11, 2023

JCR Affirmed AA-/Stable and J-1+ on Takeda Pharmaceutical

Dec. 15, 2022

Takeda Pharmaceutical Acquires New Drug Candidate for USD 4 Billion - Limited Impact on Rating

Oct. 03, 2022

JCR Upgraded Rating on Takeda Pharmaceutical to AA-/Stable and J-1+

Jun. 15, 2022

Highlights of Major Pharmaceutical Companies' Financial Results for Fiscal Year Ended March 2022

Oct. 08, 2021

JCR Assigned A+ Rating to Bonds of Takeda Pharmaceutical